Eli Lilly

In the last 10 minutes

Eli Lilly escalates its fight against black market weight-loss superdrug Irish Examiner16:18

In the last 4 hours

Lilly Escalates Legal Battle To Shut Down Retatrutide Black Market RTT News13:38

Lilly sues over 'illegal sales' of obesity drug retatrutide pharmaphorum12:32

InduPro Closes $77 Million Series B Financing and Doses First Patient in Phase 1 Study of Lead… Business Wire (Press Release)12:32

Veeva Vault CRM selected by Eli Lilly European Pharmaceutical Manufacturer12:31

In the last 6 hours

Why This Growth Stock Manager Likes Both the AI Trade and Eli Lilly MorningStar.com11:18

PBS failure to list Mounjaro for type-2 diabetics questioned ABC Online11:07

Eli Lilly takes aim at illicit market for its experimental weight-loss drug CBS News11:07

Eli Lilly escalates fight against black market weight-loss medicines The Hindu Business Line11:03

Lilly calls on online platforms, payment companies and regulators to shut down the illegal… PR Newswire (Press Release)10:30

In the last 8 hours

Mounjaro could still get on the PBS, says Eli Lilly CEO ABC Online10:17

Earlier today

Better Buy: Eli Lilly vs. Novo Nordisk The Motley Fool01:37

Yesterday

Mounjaro maker’s Foundayo weight-loss pill given MHRA approval Read Now Pulse16:17 11-Aug-26

La solution Veeva Vault CRM a été sélectionnée par Eli Lilly and Company PR Newswire (Press Release)15:11 11-Aug-26

UK first in Europe to approve Eli Lilly oral weight loss drug France 2412:28 11-Aug-26

Veeva Vault CRM seleccionado por Eli Lilly and Company PR Newswire (Press Release)12:04 11-Aug-26

Veeva Vault CRM von Eli Lilly and Company ausgewählt PR Newswire (Press Release)12:04 11-Aug-26

Veeva Vault CRM Selected by Eli Lilly and Company PR Newswire (Press Release)12:04 11-Aug-26

Eli Lilly’s Foundayo authorised by UK MHRA for weight loss and type 2 diabetes PMLiVE11:05 11-Aug-26

Eli Lilly's Foundayo Wins UK Approval RTT News08:46 11-Aug-26

Eli Lilly’s Foundayo becomes first oral weight-loss drug approved in UK for diabetes The Economic Times03:24 11-Aug-26

In the last 7 days

Why Eli Lilly Topped the Market Today The Motley Fool23:31 10-Aug-26

New partnership expands patient access to cancer clinical trials News-Medical.Net19:41 10-Aug-26

UChicago Medicine Comprehensive Cancer Center partners with Lilly to expand clinical trial access Newswise (Press Release)18:13 10-Aug-26

CPHI Milan unveils 2026 conference programme European Pharmaceutical Manufacturer14:43 10-Aug-26

Business executives explain what brought their companies to Alabama at BCA conference Alabama Daily News01:57 9-Aug-26

Better GLP-1 Stock to Buy: Eli Lilly or Viking Therapeutics? The Motley Fool20:51 8-Aug-26

Eli Lilly's Timing of the FDA Filing of Its Next Weight-Loss Drug Is Now Official -- and Novo Nordisk Has a Problem The Motley Fool23:40 7-Aug-26

Eli Lilly Launches Attacks Of Tirzepatide Generics Law36021:06 7-Aug-26

Pfizer's Next Weight-Loss Weapon: How Berobenatide Stacks Up Against Novo Nordisk's Wegovy and Eli Lilly's Zepbound The Motley Fool20:36 7-Aug-26

CVS Health (CVS) Is Down 8.6% After Raising EPS Outlook And Expanding GLP-1 Offerings - Has The Bull Case Changed? Simply Wall St08:42 7-Aug-26

Will Strong Q2 Results and Higher 2026 Outlook Change Eli Lilly's (LLY) Narrative? Simply Wall St08:42 7-Aug-26

Eli Lilly, Novo Nordisk Antitrust Suit Tossed By Texas Judge Law36020:19 6-Aug-26

Eli Lilly Earnings: Strong Q2 and Higher Margin Expectations MorningStar.com15:39 6-Aug-26

The Next Billion-Dollar Opportunity in Alzheimer's Disease Market: 6 Pipeline Therapies to… PR Newswire (Press Release)15:33 6-Aug-26

Eli Lilly Stock: Analyst Estimates & Ratings Barchart11:27 6-Aug-26

Eli Lilly raises 2026 outlook again as Q2 soars past estimates Pharmaceutical Technology11:19 6-Aug-26

AI tool aims to accelerate Alzheimer's treatment through faster referrals News-Medical.Net04:12 6-Aug-26

Why Eli Lilly Stock Climbed Today The Motley Fool23:42 5-Aug-26

Eli Lilly’s Obesity Drugs Drive Massive Revenue Growth Forbes22:20 5-Aug-26

LLY Stock Alert: What to Know as Eli Lilly Teams Up With CVS on Weight-Loss Drugs Barchart21:00 5-Aug-26

Revive Rx Can't End Eli Lilly's Suit Over Tirzepatide Drugs Law36020:24 5-Aug-26

Team’s AI agent to speed Alzheimer’s treatment Newswise (Press Release)20:09 5-Aug-26

GLP-1 drugs are driving higher sales for Eli Lilly and Novo Nordisk Global News20:08 5-Aug-26

Eli Lilly raises annual revenue expectation as GLP-1 drugs fuel growth The Business Standard20:04 5-Aug-26

Market movers: Shopify, Uber, Eli Lilly, SolarEdge, CVS Health… Proactive Investors (Canada)19:32 5-Aug-26

Everything is good in the markets for earnings: David Bahnsen Fox News18:24 5-Aug-26

Stock Market Midday, Aug. 5: Eli Lilly Pops and AMD Drops in Mixed Morning Markets The Motley Fool17:56 5-Aug-26

Novo Nordisk not currently in a position to pursue large-scale M&A, CEO says Pharmaceutical Technology17:22 5-Aug-26

Eli Lilly's Weight-Loss Empire Keeps Expanding As Mounjaro, Zepbound Generate Nearly $15 Billion Benzinga17:11 5-Aug-26

Nasdaq Falls Over 100 Points; Eli Lilly Shares Gain On Upbeat Earnings Benzinga17:01 5-Aug-26

CVS Targets Affordable GLP-1 Access With New Eli Lilly Deal Benzinga16:20 5-Aug-26

Drug Compounder Loses Bid to Toss Lilly’s Suit Over GLP-1 Copies Bloomberg Law16:19 5-Aug-26

Eli Lilly Raises Sales Forecast As Weight Loss Drug Demand Soars. Its Stock is Climbing IBTimes (US)16:08 5-Aug-26

Michigan Supreme Court Expands Consumer Protection Act JD Supra15:53 5-Aug-26

Eli Lilly stock surges 6% after Q2 earnings beat driven by Mounjaro, Zepbound Invezz15:30 5-Aug-26

Eli Lilly And Company Stock Rises 6% Over Strong Q2 Results RTT News15:23 5-Aug-26

Eli Lilly shares rise on revenue beat, raised outlook Proactive Investors (US)14:52 5-Aug-26

Sales in weight-loss drug Mounjaro double amid surging market appetite The Independent14:38 5-Aug-26

Eli Lilly (LLY) Q2 Earnings and Revenues Surpass Estimates Zacks14:21 5-Aug-26

Lilly boosts guidance on strong demand for obesity drugs Irish Examiner14:02 5-Aug-26

Mounjaro sales double this year as obesity drug boom prevails, says maker Evening Standard13:44 5-Aug-26

Eli Lilly lifts FY guidance as Mounjaro, Zepbound drive Q2 sales ShareCast13:43 5-Aug-26

Lilly's GLP-1s race away in Q2, though Foundayo falls short pharmaphorum13:40 5-Aug-26

Dow Jones and S&P 500 set to notch new highs despite AMD and SpaceX falls Proactive Investors (US)13:21 5-Aug-26

Eli Lilly ups revenue forecast as GLP-1 drugs fuel growth RTE12:56 5-Aug-26

Eli Lilly raises annual revenue forecast as GLP-1 drugs fuel growth BNN Bloomberg12:54 5-Aug-26

Eli Lilly lifts full-year forecast after revenue jumps 48% in second quarter Sweden Herald12:37 5-Aug-26

Eli Lilly Boosts FY26 Revenue Outlook; Stock Up 5.2% - Update RTT News12:35 5-Aug-26

Eli Lilly (NYSE:LLY) Beats Expectations in Strong Q2 CY2026, Full-Year Outlook Slightly Exceeds Expectations Barchart12:21 5-Aug-26

In the last month

Eli Lilly Could Swing $65.9 Billion After Earnings Benzinga20:40 4-Aug-26

Novo Nordisk stock falls despite outlook hike as Wegovy sales miss hopes Invezz20:10 4-Aug-26

Here’s How Much Traders See Eli Lilly Stock Moving After Earnings Investopedia16:58 4-Aug-26

Eli Lilly (LLY) Wins FDA Breakthrough Status For Olomorasib In Pancreatic Cancer Simply Wall St16:21 4-Aug-26

How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q2 Earnings Benzinga13:12 4-Aug-26

Eli Lilly to Offer Early Access to Next-Gen Obesity Drug to Some Patients The Business of Fashion12:50 4-Aug-26

Eli Lilly Is Up 7% in 2026 and Has Major Catalysts on the Way. Is the Rally Just Getting Started? The Motley Fool12:47 4-Aug-26

FDA grants breakthrough therapy designation to Lilly’s olomorasib Pharmaceutical Business Review10:49 4-Aug-26

Amplia Therapeutics partners with Lilly on lung cancer combination trial Proactive Investors (Australia)04:15 4-Aug-26

South Bend church among 15 Indiana African American historic sites receiving restoration grants WNDU TV 16, Indiana03:08 4-Aug-26

Michigan Supreme Court Opens Door to Increased Mcpa Enforcement: Key Takeaways from Eli Lilly National Law Review23:00 3-Aug-26

Resilience and Lilly Invest $750M to Increase U.S.-Manufactured Medicine Supply American Pharmaceutical Outsourcing (Press Release)21:31 3-Aug-26

Is Eli Lilly Stock Running out of Steam? The Motley Fool18:39 3-Aug-26

STAT Plus: After Eli Lilly granted one man special access to obesity drug, doctors struggle to… STAT18:30 3-Aug-26

See Which Recent 13F Filers Hold LLY Nasdaq16:14 3-Aug-26

GLP-1 battle heats up again as Novo claws its way back into race The Independent15:28 3-Aug-26

STAT Plus: Michigan Supreme Court ruling allows probe into Lilly insulin pricing STAT14:16 3-Aug-26

Eli Lilly Could Swing Over $76 Billion In Value After Earnings Benzinga13:40 3-Aug-26

Eli Lilly: FDA Grants Breakthrough Therapy Designation To Olomorasib RTT News13:16 3-Aug-26

Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of… PR Newswire (Press Release)12:49 3-Aug-26

Eli Lilly (LLY) Stock Looks Cheap Even As Broader Checks Stay Mixed Simply Wall St16:11 2-Aug-26

Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool13:08 2-Aug-26

Prediction: Eli Lilly Will Be Worth $2 Trillion by 2031 The Motley Fool21:21 1-Aug-26

Split Michigan Supreme Court overturns rules against insulin maker, setting new precedent Michigan Public14:55 1-Aug-26

Eli Lilly Stock Has Skyrocketed. Novo Nordisk Has Crashed. 1 Number Explains Why They're Not Even Close Anymore. The Motley Fool18:43 31-Jul-26

Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know Zacks15:05 31-Jul-26

Resilience and Lilly to increase US medicines production with $750m investment Pharmaceutical Technology10:26 31-Jul-26

The same 10mg Zepbound costs $449 or $699 The Health Care Blog00:24 31-Jul-26

Resilience And Lilly Expands U.S. Manufacturing With $750 Million Investment RTT News15:04 30-Jul-26

Jim Cramer: Eli Lilly Is A 'Good Company,' But Doesn't 'Really Care For' This Quantum Stock Benzinga13:20 30-Jul-26

Meet the Stock That's Obliterating Eli Lilly, Johnson & Johnson, and AbbVie Right Now The Motley Fool22:17 29-Jul-26

Forget Weight Loss Drugs: Here's Another Reason to Buy Eli Lilly Stock The Motley Fool13:29 29-Jul-26

Watch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming … The Motley Fool12:59 29-Jul-26

Johnson & Johnson vs. Eli Lilly: Reliable Stability vs. Rapid Revenue Growth The Motley Fool12:28 29-Jul-26

Ahead of Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued? MorningStar.com11:28 29-Jul-26

Eli Lilly Is Acquiring AtaiBeckley for $2.8 Billion. Cathie Wood Thinks Another Psychedelic Drug Stock Is an Even… The Motley Fool10:16 29-Jul-26

Hanmi Pharm's Q2 operating profit doubles on Rosuzet growth, Eli Lilly licensing deal Korea Biomedical Review05:47 29-Jul-26

Eli Lilly (LLY) Rises Higher Than Market: Key Facts Zacks23:50 28-Jul-26

Selling The Skinny Above the Law22:25 28-Jul-26

Eli Lilly Just Made a $2.8 Billion Bet That Goes Beyond GLP-1 Drugs The Motley Fool17:37 28-Jul-26

Here's How LLY's Non-GLP-1 Portfolio Is Poised Ahead of Q2 Earnings Zacks17:23 28-Jul-26

New Hampshire Hospital Sues Lilly Over Demands Under Drug Plan Bloomberg Law16:56 28-Jul-26

With a little help from pharma friends: Psychedelics for psychiatric therapy The Economic Times19:35 24-Jul-26

Why Is Novo Nordisk Suing Eli Lilly, and What Does it Mean for Investors? The Motley Fool18:08 24-Jul-26

Eli Lilly-backed Scribe Therapeutics climbs 67% after raising $128.7 million in an upsized IPO Mint18:04 24-Jul-26

view more headlines

12 Aug 16:18

About our Eli Lilly news

Latest news on on Eli Lilly and Company, an American pharmaceutical with headquarters in Indianapolis.

Eli Lilly

About our Eli Lilly news

Pharmaceuticals Top Stories

UK Top Stories

World Top Stories